Team uses AlphaFold AI to redesign gene-editing proteins to make them safer
Google's AlphaFold can help ID what parts of a gene editing protein enable mistakes. O recorte ajuda a contextualizar a pauta dentro de Tech.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
Redesigned lung cancer drug matches tumor control with fewer off-target interactions
Researchers at Moffitt Cancer Center have developed a new chemical approach that could help make targeted cancer medicines safer and more precise. The discovery gives scientists a new way to design drugs that bind more selectively to cancer-driving proteins while reducing unwante
Malaria parasite selectively consumes linoleic acid fats, revealing drug target potential
Researchers at NYU Abu Dhabi have discovered that the malaria parasite relies on a specific type of fat to survive and multiply within the human host, uncovering a previously unknown vulnerability that could help guide future treatments.
Invertebrates can distinguish good from bad bacteria
Researchers from Heinrich Heine University Düsseldorf (HHU) and Kiel University (CAU) have examined immune system function in an early-branching animal—a sea anemone. They discovered that the immune systems of these animals can selectively distinguish between different microorgan
Cellular transporter protein essential for nutrient absorption in pathogenic fungi may off
They are the cell's "gatekeepers": specialized proteins, known as transporters, selectively control which substances enter a cell and which do not. Researchers at the University of Münster and the National and Kapodistrian University of Athens have investigated these transporters
Natural peptide switches from calmodulin to the cancer-associated protein midkine dependin
Proteins regulate a wide range of biological processes inside and outside cells by binding to specific molecular partners. In recent years, short peptides that can selectively recognize disease-related proteins have attracted attention as compact molecular tools for biosensors, d
Dementia-causing substance turns into a therapeutic 'switch' with new Alzheimer's drug str
A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new therapeutic approach that uses hydrogen peroxide (H₂O₂), a reactive oxygen species that damages cells and increases in the brains of patients with Alzheimer's
Researchers develop a new prodrug and localized drug delivery platform for selective treat
A new collaborative study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR and other kinases with controlled release in tumor microenvironments to improve therapeutic efficacy, with promising results. The research is published in Bi